ab-205
Cell therapyexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started May 7, 2019 (NCT03925935)
Timeline
Indications
Mechanism of action
- Unspecified targetTissue restoration
tissue restoration
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05181540 | Phase 3 | Feb 21, 2022 | Angiocrine Bioscience, California Institute for Regenerative Medicine (CIRM) |
| NCT03925935 | Phase 1 | May 7, 2019 | Angiocrine Bioscience, California Institute for Regenerative Medicine (CIRM) |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Angiocrine Bioscience | For profit | 2 | 2 | 2 | 2019 |
| California Institute for Regenerative Medicine (CIRM) | Academic/Hospital | 2 | 0 | 2 | 2019 |
2 organizations
Page 1 / 1